The Share and Stock Market is one of the most important ways for companies to raise their money through shares, and the objective of this blog is to provide you daily intraday news regarding stock market. You have arrived at the right place and you'll find a lot of information here on intraday news updates— basic concepts, strategies for buying and selling, time of entry and exit and a lot more.
Sun Pharma's Mohali plant out of US FDA's Import Alert list
Drug major Sun Pharmaceutical Industries Ltd on Tuesday said its production facility in Mohali in Punjab is out of US Food and Drug Administration's (US FDA) "Import Alert". In a statement, Sun Pharma said the US FDA on Monday informed that it will lift the Import Alert imposed on the Mohali manufacturing facility and remove the facility from the Official Action Initiated (OAI) status.
"This proposed action will clear the path for Sun Pharma to supply approved products from the Mohali facility to the US market, subject to normal US FDA regulatory requirements," Sun Pharma said. The Mohali facility was inherited by Sun Pharma as part of its acquisition of Ranbaxy Laboratories Ltd. in 2015.